Article
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
Journal of cellular and molecular medicine - 1 Aug 2016
Sabapathy Vikram, Kumar Sanjay
Abstract excerpt
Mesenchymal stem cells (MSCs) are being assessed for ameliorating the severity of graft-versus-host disease, autoimmune conditions, musculoskeletal injuries and cardiovascular diseases. While most of these clinical therapeutic applications require substantial cell quantities, the number of MSCs that can be obtained initially from a single donor remains limited. The utility of MSCs derived from human-induced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
